Cohen David E
SEC insider (Form 3/4/5 filer). CIK 0001347383. Director at Evommune, Inc. (EVMN). 5 reported Form 4/5 transactions since Sep 2024; latest on Jun 2, 2026. Located in PALO ALTO, CA.
Companies Cohen David E has filed insider reports for
- Evommune, Inc. (EVMN): Director
Cohen David E
CIK: 0001347383
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)2 (40.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (40.0%)
Compensation grants
Other (G, F, J, C, D, …)1 (20.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
EVMN
Evommune, Inc.
Director
Discretionary Trading P&L
Holdings
Transaction History (5 total)
- Jun 2, 2026EVMN
Evommune, Inc.
SaleDirect5.5K shares at avg. $20.21$110K - Jun 2, 2026EVMN
Evommune, Inc.
SaleDirect600 shares at avg. $21.38$13K - Jun 2, 2026EVMN
Evommune, Inc.
AwardDirectStock Option (Right to buy)
15.7K shares- - Nov 7, 2025EVMN
Evommune, Inc.
ConversionDirect6.1K shares- - Nov 5, 2025EVMN
Evommune, Inc.
AwardDirectStock Option (Right to Buy)
38K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 2, 2026 | EVMN Evommune, Inc. | Sale | 5,456 | $20.21 | $110,266 | Direct |
| Jun 2, 2026 | EVMN Evommune, Inc. | Sale | 600 | $21.38 | $12,828 | Direct |
| Jun 2, 2026 | EVMN Evommune, Inc. | Award Stock Option (Right to buy) | 15,673 | - | - | Direct |
| Nov 7, 2025 | EVMN Evommune, Inc. | Conversion | 6,056 | - | - | Direct |
| Nov 5, 2025 | EVMN Evommune, Inc. | Award Stock Option (Right to Buy) | 37,960 | - | - | Direct |
1-5 of 5 transactions